Help lower costs with biosimilars We actively promote evidence-based use of biosimilars to help you make the most of your integrated drug strategy. Breadcrumb Home Our solutions Condition...

publications High Cost Therapy Profile: January 2025 Tabelecleucel Intravenous (IV) Oncology January 8, 2025 Proposed indications Epstein-Barr virus-positive (EBV+) post-transplant...

Special Investigations Unit helps promote safety to prevent fraud, waste and abuse schemes

Expert Clinical Network Insights Hemophilia December 17, 2024 Medication insights: marstacimab-hncq (Hympavzi) The U.S. Food and Drug Administration (FDA) approved marstacimab-hncq (Hympavzi) in...

publications Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches July 31, 2024 Specialty New drugs Jun. 20,...

In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

publications Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches February 28, 2025 Specialty New drugs...

PUBLICATIONS FDA Decisions Expected: February 2025 Drug pipeline for February 2025 January 15, 2025 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we...

PUBLICATIONS FDA Decisions Expected: May 2025 Your monthly synopsis of new drugs expected to hit the market April 14, 2025 Drug pipeline for May 2025 At Prime Therapeutics (Prime), we have...

Event features discussions about health care industry trends, best practices and innovations

Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

publications High-Cost Therapy Profile: May 2025 Vusolimogene oderparepvec Intratumoral | Replimune Oncology-Gene therapy May 15, 2025 Proposed indications Advanced melanoma FDA approval...

Reimagine your pharmacy benefit partner Designed by health plans for health plans, we provide an innovative pharmacy benefit manager (PBM) partnership experience. Breadcrumb Home Who we are About...

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

Drug Approvals Quarterly Update: July 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process. Prime...

Drug Approvals September 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and...

Drug Approvals Quarterly Update: January 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

publications Drug Approvals: December 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches December 30, 2024 Specialty New drugs...